Human in vivo Perturb Seq: New Insights into Human Inflammatory Disease
Thursday, January 28, 2027 at 4:40 PM to 5:10 PM · 30 min. (Europe/London)
Single-Cell Stage
Day 2 - Thursday 28th January
Single-Cell
Information
- Human tissue biopsies analysed by single cell RNAseq and spatial imaging can provide insights into mechanisms of driving tissue pathology in immune mediated inflammatory disease
- In vivo perturbation seq through delivery of therapeutics and temporal human tissue biopsies can provide novel insights into mechanisms of action, in vivo pharmacology and mechanisms of therapeutic resistance
- Curing chronic tissue pathologies will require understanding of what healthy tissue is thus, thus we have developed a genomic biomarker for degree of return to normal healthy tissue.
